Structural Genomix Appoints Prospect Genomics Founder, Exelixis Founder to Board | GenomeWeb

NEW YORK, July 19 - Structural Genomix has appointed Bill Rutter and Stelios Papadopoulos to the company's board of directors, the company said Thursday.

Rutter is a co-founder of Prospect Genomics, a San Francisco-based developer of protein structure prediction software  that was acquired in April by Structural Genomix. In addition, Rutter is a founder and chairman emeritus of Chiron, and has served as chairman of the biochemistry and biophysics department at the University of California, San Francisco.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.

The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.

The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.

In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.